What Researchers Did
This review article discussed the rationale, clinical application, and potential complications of hyperbaric oxygen therapy (HBOT) as an adjunctive treatment for diabetic foot ulcers.
What They Found
While HBOT for diabetic foot ulcers was initially based on weak evidence, two recent well-designed randomized, double-blind, placebo-controlled studies have provided stronger support for its use. These studies suggest that identifying specific inclusion criteria can help pinpoint a select group of diabetic patients with hard-to-heal ulcers who could benefit from HBOT.
What This Means for Canadian Patients
For Canadian patients with hard-to-heal diabetic foot ulcers, hyperbaric oxygen therapy may offer an effective adjunctive treatment option. Careful patient selection based on established criteria is crucial to maximize the potential benefits of this therapy.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As a review article, this study synthesizes existing literature and does not present new primary research data or clinical trial findings.